市场调查报告书
商品编码
1451213
2024-2032 年按产品、适应症(慢性阻塞性肺病、气喘、睡眠呼吸中止症、传染病等)、最终用户和地区分類的呼吸护理设备市场报告Respiratory Care Devices Market Report by Product, Indication (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Infectious Disease, and Others), End-User, and Region 2024-2032 |
2023年,全球呼吸照护设备市场规模达到219亿美元。展望未来, IMARC Group预计到2032年市场规模将达到424亿美元,2024-2032年复合年增长率(CAGR)为7.4%。
呼吸照护设备是指用于诊断、治疗、评估和照护肺部疾病患者的医疗设备。雾化器、吸入器、气道正压通气 (PAP) 装置、肺活量计、加湿器等是一些最常用的呼吸护理装置。这些设备主要执行诊断、治疗和监测功能。它们透过向肺部提供充足的氧气并防止呼吸过程中出现任何阻塞来帮助确保呼吸过程顺利进行。
慢性阻塞性肺病(COPD)、气喘和结核病等呼吸系统疾病的盛行率不断上升,是推动市场成长的关键因素。久坐的生活方式和紧张的生活习惯,加上吸烟者数量和饮酒率的增加,导致肺癌和其他严重呼吸道疾病的发病率上升。此外,早产数量的增加以及老年人口的增加也影响了对呼吸照护设备的需求。早产儿和老年人的免疫系统往往较弱,需要各种呼吸支持装置来促进人工呼吸和预防呼吸系统疾病,包括新生儿呼吸窘迫症候群(RDS)。其他因素,例如医疗保健支出的增加和微型设备的开发,预计将进一步推动市场。政府和非政府组织 (NGO) 为向所有人提供优质医疗保健设施所做的重大努力,以及开发新的和改善现有的医疗保健基础设施,也为市场创造了积极的前景。
The global respiratory care devices market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices. These devices primarily perform diagnostic, therapeutic and monitoring functions. They aid in ensuring a smooth respiration process by providing an adequate amount of oxygen to the lungs and preventing any blockage in the process.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and tuberculosis, represent as the key factors driving the growth of the market. Sedentary lifestyles and stressful routines, in confluence with the growing number of smokers and rate of alcohol consumption, have resulted in rising incidences of lung cancer and other severe respiratory conditions. Also, the increasing number of premature births, along with the growing geriatric population are also impacting the demand for respiratory care devices. Both premature newborns and elderly tend to have weak immune systems and require various breathing support devices for facilitating artificial breathing and preventing respiratory disorders, including newborn respiratory distress syndrome (RDS). Other factors, such as the increasing healthcare expenditure and the development of miniature devices are projected to drive the market further. Significant efforts by both the government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all, along with developing new and improving the existing healthcare infrastructure are also creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory care devices market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product, indication and end-user.
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Ventilators
Nebulizers
Humidifiers
Inhalers
Other
Monitoring Devices
Pulse Oximeters
Gas Analyzers
Others
Diagnostic Devices
Spirometers
Polysomnography Devices
Peak Flow Meters
Others
Consumables and Accessories
Masks
Disposable Resuscitators
Breathing Circuits
Tracheostomy Tubes
Nasal Cannulas
Others
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Sleep Apnea
Infectious Disease
Others
Hospitals
Home Care Settings
Ambulatory Care Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, ResMed, Chart Industries Inc., Hamilton Medical, Medtronic, Masimo, Dragerwerk, Invacare Corporation, Allied Healthcare Products Inc, 3B Medical Inc., Air Liquide, Fisher & Paykel Healthcare, GE Healthcare, Vyaire Medical Inc., Rotech Healthcare Inc., etc.